In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Christoph Maack
Speaker
Christoph Maack
Christoph Maack Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

Specialities : Chronic Heart Failure , Ventricular Arrhythmias and Sudden Cardiac Death (SCD)

Christoph Maack received his MD at the University of Cologne (Germany) in 2000. From 2000 to 2017, he worked at the Department of Cardiology at the University of the Saarland in Homburg, Germany. Between 2002 and 2005, he was a post-doc in the lab of Brian O’Rourke at the Department of Cardiology at Johns Hopkins University in Baltimore, MD, US. In 2017, he became Spokesperson of the Comprehensive Heart Failure Center (CHFC) at the University Clinic in Würzburg, Germany, where he also chairs the Department of Translational Science. His work focuses on cellular defects in chronic heart failure, with a special emphasis on the mechanisms of contractile, mitochondrial and metabolic dysfunction in heart failure.

34 presentations from this speaker

Abnormal mitochondrial calcium handling in hypertrophic cardiomyopathy: Arrhythmogenic mechanism or bystander?

Event : ESC Congress 2019

  • Session : Out of Control: proarrhythmic calcium handling from bench to bedside
  • Speaker : C Maack (Wuerzburg,DE)

Beta-blockers in hypertensive patients with comorbidities: where do we stand?

Event : ESC Congress 2019

  • Session : Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by Servier

Discussion

Event : ESC Congress 2019

  • Session : Combinations of beta-blockers and angiotensin-converting enzyme inhibitors: what is the rationale?
  • Speaker : C Maack (Wuerzburg,DE), J Wolf (Gdansk,PL), C Tsioufis (Athens,GR)
  • Sponsored by Servier

Elamipretide, to block mitochondrial dysfunction?

Event : Heart Failure 2019

  • Session : Upcoming and novel drugs in heart failure
  • Speaker : C Maack (Wuerzburg,DE)

Mechanisms of disease and treatments.

Event : Heart Failure 2019

  • Session : Diabetes and heart failure
  • Speaker : C Maack (Wuerzburg,DE)

Mitochondrial dysfunction in cardiovascular disease: an overview .

Event : ESC Congress 2019

  • Session : Mitochondria as orchestrators of cardiovascular function
  • Speaker : C Maack (Wuerzburg,DE)

Bioenergetic aspects of inotropes

Event : Heart Failure 2018

  • Session : Positive inotropy - Still an approach we should go for?
  • Speaker : C Maack (Wuerzburg,DE)

Combining bench work with bedside manner - How to have a career in basic research and clinical medicine?

Event : Heart Failure 2018

  • Session : Planning a career in cardiovascular medicine
  • Speaker : C Maack (Wuerzburg,DE)

Detection of cytosolic, mitochondrial and nuclear calcium in cardiomyocytes.

Event : Frontiers in CardioVascular Biology 2018

  • Session : Novel fluorescent sensors to detect intracellular signalling
  • Speaker : C Maack (Wuerzburg,DE)

Improvement of cardiac efficiency: a question of combination.

Event : Heart Failure 2018

  • Session : Optimizing heart failure treatments before discharge
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

Role of mitochondrial dysfunction in contractile deficit and arrhythmias in HF

Event : Frontiers in CardioVascular Biology 2018

  • Session : Molecular basis for arrhythmias and beyond
  • Speaker : C Maack (Wuerzburg,DE)

20 years of metabolic remodeling.

Event : Heart Failure 2017

  • Session : Hot insights in metabolic interventions
  • Speaker : C Maack (Wuerzburg,DE)

Discussion.

Event : Heart Failure 2017

  • Session : Managing heart failure patients in day-to-day practice
  • Speaker : A Coats (Warwickshire,GB), C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

How to keep patients out of hospital?

Event : ESC Congress 2017

  • Session : Filling the gaps in heart failure treatment
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

How to keep the patient out of the hospital.

Event : Heart Failure 2017

  • Session : Managing heart failure patients in day-to-day practice
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

Hypertrophic cardiomyopathy

Event : Heart Failure 2017

  • Session : Understanding cardiomyopathies. What are the mechanisms?
  • Speaker : C Maack (Wuerzburg,DE)

Inotropes: a "catch-22".

Event : Heart Failure 2017

  • Session : Highlights of translational medicine
  • Speaker : C Maack (Wuerzburg,DE)

Basic and translational science.

Event : Heart Failure 2016

  • Session : Heart Failure 2016 Highlights
  • Speaker : C Maack (Wuerzburg,DE)

Improving systolic function at the core of the journey.

Event : Heart Failure 2016

  • Session : Optimizing heart failure care: if not now, when?
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

Metabolic stress.

Event : ESC Congress 2016

  • Session : Heart failure with preserved ejection fraction
  • Speaker : C Maack (Wuerzburg,DE)

New devices and drugs to improve symptoms in heart failure.

Event : Heart Failure 2016

  • Session : How to implement the new ESC guidelines on heart failure in clinical practice
  • Speaker : C Maack (Wuerzburg,DE)
  • Organised by Charité Medical School Berlin

Novel drugs in heart failure: what's on the horizon?

Event : Heart Failure 2016

  • Session : Novel drugs - how do they work?
  • Speaker : C Maack (Wuerzburg,DE)

Treatments in heart failure – Lessons from the lab

Event : ESC Congress 2016

  • Session : Cardiovascular therapeutics in 2020 – What’s on the horizon?
  • Speaker : C Maack (Wuerzburg,DE)

Basic and translational science.

Event : Heart Failure 2015

  • Session : Heart Failure 2015 Highlights
  • Speaker : C Maack (Wuerzburg,DE)

Basic mechanisms to improve systolic function.

Event : Heart Failure 2015

  • Session : Clinical fundamentals of systolic and diastolic function
  • Speaker : C Maack (Wuerzburg,DE)

Ca2+/Calmodulin-dependent protein kinase II does not control mitochondrial Ca2+ uptake in cardiac myocytes

Event : Heart Failure 2015

  • Session : Basic Science: EC coupling and arrhythmias
  • Speaker : C Maack (Wuerzburg,DE)

Cardiac efficiency through improvement in systolic function in heart failure.

Event : EuroEcho 2015

  • Session : Improvement of cardiac efficiency at the heart of cardiovascular management
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

How mitochondrial ROS production triggers arrhythmias in hypertrophic cardiomyopathy.

Event : EHRA 2015

  • Session : Oxidative stress and membrane excitability 
  • Speaker : C Maack (Wuerzburg,DE)

Ivabradine to improve cardiac function.

Event : Heart Failure 2015

  • Session : Preventing heart failure rehospitalization: a collaborative effort
  • Speaker : C Maack (Wuerzburg,DE)
  • Sponsored by SERVIER

Management of heart failure with chronic kidney disease.

Event : ESC Congress 2015

  • Session : Heart failure 2015: update for the clinician
  • Speaker : C Maack (Wuerzburg,DE)

Mitochondria: the ultimate target in heart failure therapy?

Event : Heart Failure 2015

  • Session : Metabolic targets in heart failure
  • Speaker : C Maack (Wuerzburg,DE)

Mitochondria-targeted therapies.

Event : Heart Failure 2015

  • Session : Novel drugs: how do they work?
  • Speaker : C Maack (Wuerzburg,DE)

Which drugs are cardiotoxic and why?

Event : ESC Congress 2014

  • Session : Cardio-oncology in practice
  • Speaker : C Maack (Wuerzburg,DE)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are